Annual gross profit:
$28.54B+$1.46B(+5.38%)Summary
- As of today (April 16, 2025), GSK annual gross profit is $28.54 billion, with the most recent change of +$1.46 billion (+5.38%) on December 1, 2024.
- During the last 3 years, GSK annual gross profit has risen by +$5.79 billion (+25.46%).
- GSK annual gross profit is now -18.65% below its all-time high of $35.08 billion, reached on December 31, 2007.
Performance
GSK Gross profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly gross profit:
$7.12B-$190.37M(-2.61%)Summary
- As of today (April 16, 2025), GSK quarterly gross profit is $7.12 billion, with the most recent change of -$190.37 million (-2.61%) on December 1, 2024.
- Over the past year, GSK quarterly gross profit has stayed the same.
- GSK quarterly gross profit is now -42.13% below its all-time high of $12.30 billion, reached on September 30, 2003.
Performance
GSK quarterly gross profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM gross profit:
$28.53B+$118.74M(+0.42%)Summary
- As of today (April 16, 2025), GSK TTM gross profit is $28.53 billion, with the most recent change of +$118.74 million (+0.42%) on December 1, 2024.
- Over the past year, GSK TTM gross profit has stayed the same.
- GSK TTM gross profit is now -18.76% below its all-time high of $35.12 billion, reached on March 31, 2008.
Performance
GSK TTM gross profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Gross profit Formula
Gross Profit = Revenue − Cost Of Goods Sold
GSK Gross profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +5.4% | 0.0% | 0.0% |
| 3 y3 years | +25.5% | +18.6% | +19.3% |
| 5 y5 years | +2.1% | +18.6% | +19.3% |
GSK Gross profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +25.5% | -4.3% | +19.1% | -0.1% | +19.3% |
| 5 y | 5-year | at high | +35.4% | -5.8% | +1441.6% | -1.8% | +55.0% |
| alltime | all time | -18.6% | +324.3% | -42.1% | +1441.6% | -18.8% | +953.3% |
GSK Gross profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $28.54B(+5.4%) | $7.12B(-2.6%) | $28.53B(+0.4%) |
| Sep 2024 | - | $7.31B(+0.5%) | $28.41B(-0.5%) |
| Jun 2024 | - | $7.27B(+6.3%) | $28.55B(+2.5%) |
| Mar 2024 | - | $6.84B(-2.2%) | $27.84B(+2.8%) |
| Dec 2023 | $27.08B(+10.6%) | $7.00B(-5.9%) | $27.09B(+3.7%) |
| Sep 2023 | - | $7.44B(+13.3%) | $26.13B(+4.3%) |
| Jun 2023 | - | $6.57B(+7.9%) | $25.06B(+2.4%) |
| Mar 2023 | - | $6.09B(+0.8%) | $24.47B(+0.4%) |
| Dec 2022 | $24.48B(+7.6%) | $6.04B(-5.0%) | $24.38B(+1.1%) |
| Sep 2022 | - | $6.36B(+6.5%) | $24.12B(+0.0%) |
| Jun 2022 | - | $5.98B(-0.4%) | $24.12B(+0.8%) |
| Mar 2022 | - | $6.00B(+3.7%) | $23.92B(-3.3%) |
| Dec 2021 | $22.75B(+7.9%) | $5.78B(-9.0%) | $24.72B(+34.3%) |
| Sep 2021 | - | $6.36B(+10.1%) | $18.41B(-5.6%) |
| Jun 2021 | - | $5.77B(-15.2%) | $19.49B(-3.2%) |
| Mar 2021 | - | $6.81B(-1383.3%) | $20.14B(-3.6%) |
| Dec 2020 | $21.08B(-24.6%) | -$530.41M(-107.1%) | $20.88B(-27.2%) |
| Sep 2020 | - | $7.44B(+16.0%) | $28.69B(-0.4%) |
| Jun 2020 | - | $6.42B(-15.0%) | $28.81B(-0.8%) |
| Mar 2020 | - | $7.55B(+3.7%) | $29.04B(+4.1%) |
| Dec 2019 | $27.95B(+1.8%) | $7.28B(-3.8%) | $27.91B(+1.7%) |
| Sep 2019 | - | $7.57B(+13.8%) | $27.44B(+1.7%) |
| Jun 2019 | - | $6.65B(+3.5%) | $26.98B(-0.6%) |
| Mar 2019 | - | $6.42B(-5.7%) | $27.15B(-1.1%) |
| Dec 2018 | $27.46B(+7.2%) | $6.81B(-4.2%) | $27.45B(+0.2%) |
| Sep 2018 | - | $7.11B(+4.3%) | $27.39B(+1.2%) |
| Jun 2018 | - | $6.81B(+1.4%) | $27.07B(+3.1%) |
| Mar 2018 | - | $6.72B(-0.4%) | $26.27B(+2.7%) |
| Dec 2017 | $25.62B(+1.7%) | $6.75B(-0.7%) | $25.58B(+1.7%) |
| Sep 2017 | - | $6.80B(+13.1%) | $25.15B(+0.8%) |
| Jun 2017 | - | $6.01B(-0.4%) | $24.94B(-1.3%) |
| Mar 2017 | - | $6.03B(-4.4%) | $25.26B(+0.7%) |
| Dec 2016 | $25.20B(+9.4%) | $6.31B(-4.3%) | $25.09B(+2.6%) |
| Sep 2016 | - | $6.59B(+4.1%) | $24.47B(+2.1%) |
| Jun 2016 | - | $6.33B(+8.0%) | $23.95B(+1.6%) |
| Mar 2016 | - | $5.86B(+3.2%) | $23.57B(+2.3%) |
| Dec 2015 | $23.03B(-10.9%) | $5.68B(-6.6%) | $23.04B(-3.7%) |
| Sep 2015 | - | $6.08B(+2.2%) | $23.94B(-1.2%) |
| Jun 2015 | - | $5.95B(+11.5%) | $24.23B(-2.1%) |
| Mar 2015 | - | $5.33B(-18.9%) | $24.74B(-4.1%) |
| Dec 2014 | $25.85B(-7.8%) | $6.58B(+3.2%) | $25.81B(-2.0%) |
| Sep 2014 | - | $6.37B(-1.4%) | $26.33B(-1.7%) |
| Jun 2014 | - | $6.46B(+0.9%) | $26.77B(-2.5%) |
| Mar 2014 | - | $6.40B(-9.7%) | $27.45B(-2.1%) |
| Dec 2013 | $28.04B(-4.4%) | $7.09B(+3.9%) | $28.03B(-2.1%) |
| Sep 2013 | - | $6.82B(-4.4%) | $28.62B(-0.6%) |
| Jun 2013 | - | $7.14B(+2.2%) | $28.81B(+0.3%) |
| Mar 2013 | - | $6.98B(-9.1%) | $28.73B(-2.0%) |
| Dec 2012 | $29.32B(-7.4%) | $7.68B(+9.6%) | $29.32B(-0.8%) |
| Sep 2012 | - | $7.01B(-0.8%) | $29.55B(-3.5%) |
| Jun 2012 | - | $7.06B(-6.7%) | $30.62B(-3.3%) |
| Mar 2012 | - | $7.57B(-4.2%) | $31.68B(+0.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2011 | $31.65B(+0.2%) | $7.90B(-2.3%) | $31.66B(+1.0%) |
| Sep 2011 | - | $8.08B(-0.4%) | $31.36B(+1.6%) |
| Jun 2011 | - | $8.12B(+7.5%) | $30.87B(+0.4%) |
| Mar 2011 | - | $7.55B(-0.7%) | $30.76B(-2.8%) |
| Dec 2010 | $31.59B(-3.9%) | $7.60B(+0.0%) | $31.64B(-6.4%) |
| Sep 2010 | - | $7.60B(-5.0%) | $33.79B(-1.6%) |
| Jun 2010 | - | $8.00B(-5.1%) | $34.35B(+0.4%) |
| Mar 2010 | - | $8.43B(-13.6%) | $34.20B(+3.9%) |
| Dec 2009 | $32.87B(-0.9%) | $9.76B(+19.6%) | $32.94B(+6.5%) |
| Sep 2009 | - | $8.16B(+3.9%) | $30.93B(+0.2%) |
| Jun 2009 | - | $7.85B(+9.7%) | $30.88B(-2.4%) |
| Mar 2009 | - | $7.16B(-7.7%) | $31.63B(-4.2%) |
| Dec 2008 | $33.17B(-5.4%) | $7.76B(-4.4%) | $33.03B(-4.0%) |
| Sep 2008 | - | $8.11B(-5.6%) | $34.40B(-1.3%) |
| Jun 2008 | - | $8.60B(+0.5%) | $34.86B(-0.7%) |
| Mar 2008 | - | $8.56B(-6.2%) | $35.12B(+0.1%) |
| Dec 2007 | $35.08B(+4.5%) | $9.13B(+6.4%) | $35.08B(+1.4%) |
| Sep 2007 | - | $8.58B(-3.2%) | $34.60B(+0.9%) |
| Jun 2007 | - | $8.86B(+4.0%) | $34.31B(+1.3%) |
| Mar 2007 | - | $8.52B(-1.5%) | $33.87B(+1.0%) |
| Dec 2006 | $33.57B(+9.2%) | $8.64B(+4.4%) | $33.54B(+1.8%) |
| Sep 2006 | - | $8.28B(-1.6%) | $32.94B(+1.9%) |
| Jun 2006 | - | $8.42B(+2.8%) | $32.33B(+2.7%) |
| Mar 2006 | - | $8.19B(+1.8%) | $31.49B(+2.6%) |
| Dec 2005 | $30.73B(+7.4%) | $8.05B(+4.9%) | $30.69B(+1.6%) |
| Sep 2005 | - | $7.67B(+1.2%) | $30.21B(+2.4%) |
| Jun 2005 | - | $7.58B(+2.6%) | $29.49B(+1.7%) |
| Mar 2005 | - | $7.39B(-2.3%) | $29.01B(+1.3%) |
| Dec 2004 | $28.63B(+3.7%) | $7.57B(+8.9%) | $28.63B(+27.5%) |
| Sep 2004 | - | $6.95B(-2.0%) | $22.46B(-19.2%) |
| Jun 2004 | - | $7.09B(+1.1%) | $27.80B(+0.7%) |
| Mar 2004 | - | $7.02B(+403.7%) | $27.62B(+1.3%) |
| Dec 2003 | $27.60B(+10.6%) | $1.39B(-88.7%) | $27.26B(-16.9%) |
| Sep 2003 | - | $12.30B(+77.9%) | $32.81B(+23.6%) |
| Jun 2003 | - | $6.91B(+3.8%) | $26.54B(+2.4%) |
| Mar 2003 | - | $6.66B(-4.0%) | $25.93B(+3.9%) |
| Dec 2002 | $24.95B(+7.6%) | $6.94B(+15.2%) | $24.96B(+1.7%) |
| Sep 2002 | - | $6.03B(-4.3%) | $24.55B(+2.1%) |
| Jun 2002 | - | $6.30B(+10.5%) | $24.05B(+2.5%) |
| Mar 2002 | - | $5.70B(-12.8%) | $23.45B(+1.2%) |
| Dec 2001 | $23.18B(+8.3%) | $6.53B(+18.1%) | $23.18B(+4.0%) |
| Sep 2001 | - | $5.53B(-3.0%) | $22.28B(+1.7%) |
| Jun 2001 | - | $5.70B(+5.1%) | $21.91B(+1.5%) |
| Mar 2001 | - | $5.42B(-3.8%) | $21.59B(+1.1%) |
| Dec 2000 | $21.40B(+218.2%) | $5.63B(+9.3%) | $21.35B(+35.9%) |
| Sep 2000 | - | $5.15B(-4.2%) | $15.71B(+48.8%) |
| Jun 2000 | - | $5.38B(+3.9%) | $10.56B(+31.4%) |
| Mar 2000 | - | $5.18B(+81.2%) | $8.04B(+181.2%) |
| Dec 1999 | $6.72B(-37.0%) | - | - |
| Jun 1999 | - | $2.86B(+5.5%) | $2.86B(+5.5%) |
| Dec 1998 | $10.67B(+21.3%) | - | - |
| Jun 1998 | - | $2.71B | $2.71B |
| Jun 1995 | $8.80B | - | - |
FAQ
- What is GSK annual gross profit?
- What is the all time high annual gross profit for GSK?
- What is GSK annual gross profit year-on-year change?
- What is GSK quarterly gross profit?
- What is the all time high quarterly gross profit for GSK?
- What is GSK quarterly gross profit year-on-year change?
- What is GSK TTM gross profit?
- What is the all time high TTM gross profit for GSK?
- What is GSK TTM gross profit year-on-year change?
What is GSK annual gross profit?
The current annual gross profit of GSK is $28.54B
What is the all time high annual gross profit for GSK?
GSK all-time high annual gross profit is $35.08B
What is GSK annual gross profit year-on-year change?
Over the past year, GSK annual gross profit has changed by +$1.46B (+5.38%)
What is GSK quarterly gross profit?
The current quarterly gross profit of GSK is $7.12B
What is the all time high quarterly gross profit for GSK?
GSK all-time high quarterly gross profit is $12.30B
What is GSK quarterly gross profit year-on-year change?
Over the past year, GSK quarterly gross profit has changed by $0.00 (0.00%)
What is GSK TTM gross profit?
The current TTM gross profit of GSK is $28.53B
What is the all time high TTM gross profit for GSK?
GSK all-time high TTM gross profit is $35.12B
What is GSK TTM gross profit year-on-year change?
Over the past year, GSK TTM gross profit has changed by $0.00 (0.00%)